-
Company Insights
New![]()
Innovation and Patenting activity of Mission Produce, Inc. Q3 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Mission Produce, Inc. Q3 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Company Insights
New![]()
Innovation and Patenting activity of Total Produce plc Q3 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Total Produce plc Q3 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Company Insights
New![]()
Innovation and Patenting activity of Fresh Del Monte Produce Inc Q3 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Fresh Del Monte Produce Inc Q3 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report...
-
Company Profile
![]()
Fresh Del Monte Produce Inc – Company Profile
Fresh Del Monte Produce Inc (Fresh Del Monte) is a global food company that manufactures, markets, and distributes bananas, fresh produce, prepared food and vegetables, and other products and services including selling of poultry and meat products. The company sources prepared food products from Europe, Africa, and the Middle East and fresh produce products from Central, North and South America, and the Philippines. Fresh Del Monte markets products under Mann's, Pinkglow, Honeyglow, UTC, Del Monte, Rosy, Just Juice, Fruitini and...
Add to Basket -
Product Insights
![]()
Produce World – Chatteris Food Factory – Cambridgeshire
Equip yourself with the essential tools needed to make informed and profitable decisions with our Produce World - Chatteris Food Factory - Cambridgeshire report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into the...
-
Sector Analysis
New![]()
Automotive Material Market Trends and Analysis by Technology, Companies and Forecast to 2028
Automotive Material Market Report Overview OEM manufacturers and suppliers are building new plants and production lines to enhance the capacity of the production process. Many companies have announced an investment in its material products. Introducing a new hybrid compound line will help produce value-added compounds for the automotive industry. The Automotive Material Market research report provides an overview of the automotive industry scenario regarding the future outlook in terms of global trends, drivers, technologies, and developments. The analysis also covers...
-
Product Insights
![]()
European Energy – Methanol producing facility – South Denmark
Equip yourself with the essential tools needed to make informed and profitable decisions with our European Energy - Methanol producing facility - South Denmark report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Sector Analysis
New![]()
Canadian Oil Sands Upstream Development Outlook by Projects Count, Operator, Production, Company and Upcoming Projects, 2023-2027
Canada Oil Sands Market Report Overview The Canadian oil sands, found in the Western Sedimentary basin of the Alberta province, are the most prolific producing resources in North America. In 2023, production from the 33 active oil sand assets reached 3.296 million barrels per day (mmbd) and is expected to register a total growth of more than 11% by 2023-2027. Canada Oil Sands Market Outlook, 2023-2027 (mmbd) Buy Full Report to Know More about the Canada Oil Sands Market Download...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Rybelsus in Obesity
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Rybelsus in Obesity Drug Details: Semaglutide (Rybelsus) is a recombinant DNA produced polypeptide analogue of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Ruti in Pulmonary Tuberculosis
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.RUTI in Pulmonary Tuberculosis Drug Details:RUTI is under development for the treatment of latent tuberculosis (TB),...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – RUTI in Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. RUTI in Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) Drug Details: RUTI is...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (Avibactam + Aztreonam) in Pyelonephritis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. (Avibactam + Aztreonam) in Pyelonephritis Drug Details: PF-06947387 (aztreonam in combination with avibactam) is under...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – MBK-001 in Metabolic Dysfunction-Associated Steatohepatitis (MASH)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. MBK-001 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Drug Details: MBK-001 is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (Avibactam + Aztreonam) in Urinary Tract Infections
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. (Avibactam + Aztreonam) in Urinary Tract Infections Drug Details: PF-06947387 (aztreonam in combination with avibactam)...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (Avibactam + Aztreonam) in Gram-Negative Bacterial Infections
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. (Avibactam + Aztreonam) in Gram-Negative Bacterial Infections Drug Details: PF-06947387 (aztreonam in combination with avibactam)...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (Avibactam + Aztreonam) in Complicated Intra-Abdominal Infections
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. (Avibactam + Aztreonam) in Complicated Intra-Abdominal Infections Drug Details: PF-06947387 (aztreonam in combination with avibactam)...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (Avibactam + Aztreonam) in Peritonitis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. (Avibactam + Aztreonam) in Peritonitis Drug Details: PF-06947387 (aztreonam in combination with avibactam) is under...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (Avibactam + Aztreonam) in Bacterial Pneumonia
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. (Avibactam + Aztreonam) in Bacterial Pneumonia Drug Details: PF-06947387 (aztreonam in combination with avibactam) is...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (Avibactam + Aztreonam) in Ventilator Associated Pneumonia (VAP)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. (Avibactam + Aztreonam) in Ventilator Associated Pneumonia (VAP) Drug Details: PF-06947387 (aztreonam in combination with...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (Avibactam + Aztreonam) in Hospital Acquired Pneumonia (HAP)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. (Avibactam + Aztreonam) in Hospital Acquired Pneumonia (HAP) Drug Details: PF-06947387 (aztreonam in combination with...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.